[Effect of human immunoglobulins on microflora of the large intestine in nonspecific ulcerative colitis].
The use of commercial preparations of human immunoglobulin for the treatment of ulcerous colitis produces a positive effect on the microflora of the large intestine, contributing to the disappearance of Proteus, the lactose-negative forms of enterobacteria and the hemolytic variants of staphylococci, as well as to the increase of the amount of useful indigenous microflora (bifidobacteria and lactobacteria). The quantitative and qualitative improvement of the microflora leads, possibly, to the decrease of the intoxication of the body, improvement in the activity of the intestine and increased vitamin formation, thus giving a pronounced clinical effect and improvement in the endoscopic picture of the mucous membrane of the large intestine, peculiar for this disease.
D000328:Adult; D000907:Antibodies, Bacterial / Q000032:analysis; D003093:Colitis, Ulcerative / Q000382:microbiology / Q000628:therapy*; D003131:Combined Modality Therapy; D004926:Escherichia coli / Q000276:immunology; D005069:Evaluation Studies as Topic; D005243:Feces / Q000382:microbiology; D006801:Humans; D007136:Immunoglobulins / Q000008:administration & dosage*; D007420:Intestine, Large / Q000382:microbiology*; D008875:Middle Aged; D013997:Time Factors
D000907:Antibodies, Bacterial; D007136:Immunoglobulins
Vliianie immunoglobulinov cheloveka na mikrofloru tolstogo kishechnika pri nespetsificheskom iazvennom kolite.